Imipramine Pamoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 9 USDMF, 1 EU WC, 1 NDC API, 3 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 16 FDA Orange Book, 8 Europe, 3 Australia, 2 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 2 Gangwal Healthcare, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Keval Exports, 3 Lonza Capsugel, 5 Microlex e.U, 1 Neelkanth MineChem, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 10 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 11 Disintegrants & Superdisintegrants, 8 Empty Capsules, 6 Direct Compression, 6 Coating Systems & Additives, 6 Taste Masking, 5 Granulation, 5 Co-Processed Excipients, 5 Thickeners and Stabilizers, 3 Film Formers & Plasticizers, 3 Chewable & Orodispersible Aids, 3 Emulsifying Agents, 2 Controlled & Modified Release, 1 API Stability Enhancers, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 Others

3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Imipramine Pamoate

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Gangwal Chemicals

filter Capability Reset all filters

filter Country Reset all filters

01

Gangwal Chemicals

FUJISIL

India Pharma Expo

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Imipramine Pamoate? Find API Stability Enhancers used in Imipramine Pamoate to address drug delivery challenges on PharmaCompass.

Imipramine Pamoate

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

9 USDMF

1 EU WC

1 NDC API

3 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers

16 FDA Orange Book

8 Europe

3 Australia

2 South Africa

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

2 Gangwal Healthcare

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 DFE Pharma

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Keval Exports

3 Lonza Capsugel

5 Microlex e.U

1 Neelkanth MineChem

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

10 Roquette

1 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Silverline Chemicals

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

15 Lubricants & Glidants

11 Disintegrants & Superdisintegrants

8 Empty Capsules

6 Direct Compression

6 Coating Systems & Additives

6 Taste Masking

5 Granulation

5 Co-Processed Excipients

5 Thickeners and Stabilizers

3 Film Formers & Plasticizers

3 Chewable & Orodispersible Aids

3 Emulsifying Agents

2 Controlled & Modified Release

1 API Stability Enhancers

1 Topical

1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

2 APIs

REF. STANDARDS & IMPURITIES

3 Others

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons